The role of venoactive drugs in the perioperative period of endovenous treatment for varicose veins

Introduction. Varicose veins of the lower extremities are the most common form of chronic venous insufficiency and remain a significant medical and social problem. Endovenous methods for eliminating pathological venous reflux (EVLA, RFA, MOCA, etc.) are currently considered the standard of surgical treatment. However, in the early postoperative period some patients continue to experience undesirable venous-specific symptoms, which are associated with thermal or mechanochemical endothelial injury and activation of inflammatory mechanisms. Despite the widespread use of venoactive drugs, their role in perioperative management during endovenous interventions and their impact on endothelial dysfunction remain a matter of discussion, which determines the relevance of the present analytical review.

Aim of the study. Analysing current data on the use of phleboactive drugs in the perioperative period of endovenous treatment of varicose veins, with a focus on their effect on markers of endothelial dysfunction, inflammation, and the severity of clinical symptoms.

Materials and methods. Available international and Russian literature analysed using the scientific databases PubMed, Google Scholar, and Scopus.

Results. The analysis has demonstrated that the use of venoactive drugs in the perioperative period contributes to a faster regression of venous-specific symptoms, a reduction in the incidence of early adverse events, and an improvement in quality-of-life indicators. A positive effect on markers of endothelial dysfunction and microcirculation was also observed, which may be considered a pathogenetically justified effect.

Conclusion. Current concepts regarding the mechanisms and clinical effectiveness of venotonic therapy in the context of endovenous interventions have been systematised. The summarised data provides a comprehensive understanding of the importance of perioperative pharmacological support.

1. Salim S., Machin M., Patterson B. O., Onida S., Davies A. H. Global Epidemiology of chronic venous disease: a systematic review with pooled prevalence analysis. Annals of surgery, 2021, no 274(6), pp. 971–976. https://doi.org/10.1097/SLA.0000000000004631

2. Avgerinos E.D., Vasdekis S.N., Kardoulas D.G., Stefanou G., Kourlaba G., Papageorgiou A.; under the auspices of the Hellenic Society of Phlebology. Prevalence of chronic venous disease and quality of life in the adult greek population: results from the veinprotect study. Eur J Vasc Endovasc Surg., 2025, no 25, pp. S1078–5884. https://doi.org/10.1016/j.ejvs.2025.09.016

3. Elkholi S.M., Alotaibi D., Alrashdi R., Bin Subeh R., Aljudeie H., Aljabr R., Mortada E.M., Alwhaibi R. M. Prevalence of varicose veins among teaching professionals and their impact on quality of life and job performance: A Cross-sectional study. Healthcare (Basel), 2025, no 13(23), pp. 3041. https://doi.org/10.3390/health-care13233041

4. Gloviczki M.L., Kakkos S.K., Urbanek T., Chuback J., Nicolaides A. The role of venoactive compounds in the treatment of chronic venous disease. J Vasc Surg Venous Lymphat Disord. 2025, no 13(5), pp. 102258. https://doi.org/10.1016/j.jvsv.2025.102258

5. Mezalek Z.T., Feodor T., Chernukha L., Chen Z., Rueda A., Sánchez, I.E., Ochoa A.J.G., Chirol J., Blanc-Guillemaud V., Lohier-Durel C., Ulloa J.H. VEIN STEP: A prospective, observational, international study to assess effectiveness of conservative treatments in chronic venous disease. Advances in therapy, 2023, no 40(11), pp. 5016–5036. https://doi.org/10.1007/s12325-023-02643-6

6. Nicolaides A.N. Chronic venous disease and the leukocyte-endothelium interaction: from symptoms to ulceration. Angiology, 2005, no 56 Suppl 1, pp. 11–19. https://doi.org/10.1177/00033197050560i103

7. Cyrino F.Z., Blanc-Guillemaud V., Bouskela E. Time course of microvalve pathophysiology in high pressure low flow model of venous insufficiency and the role of micronized purified flavonoid fraction. International angiology: a journal of the International Union of Angiology, 2021, no 40(5), pp. 388–394. https://doi.org/10.23736/S0392-9590.21.04726-X

8. Yevsyukov D.A., Tsukanov Yu.T., Kuzovkin A.N., Dorofeeva V.P., Tsukanov A.Ju., Alikberov M.H., Snitko I.O., Vinnik I.E Features of the influence of micronized purified flavonoid fraction on remodeling of the venous wall during hypodynamia in the experiment. Ambulatory Surgery, 2025, no 22(1), pp. 102–109. (In Russ.) https://doi.org/10.21518/akh2025-025

9. Kalinin R.E., Suchkov I.A., Kamaev A.A., Zvyagina V.I., Krylov A.A. Endotheliotropic effects of venotonic drugs in treatment of patients with varicose veins. Angiology and vascular surgery, 2018, no 24 (4), pp. 72–75. (In Russ.)

10. Monjotin N., Tenca G. Lymphotonic activity of Ruscus extract, hesperidin methyl chalcone and vitamin C in human lymphatic smooth muscle cells. Microvascular research, 2022, vol. 139, рр. 104274. https://doi.org/10.1016/j.mvr.2021.104274

11. Das Graças C de Souza M., Cyrino F., de Carvalho J.J., Blanc-Guillemaud V., Bouskela E. Protective effects of micronized purified flavonoid fraction (mpff) on a novel experimental model of chronic venous hypertension. Eur J Vasc Endovasc Surg., 2018, no 55(5), pp. 694–702. https://doi.org/10.1016/j.ejvs.2018.02.009

12. Mansilha A. Early stages of chronic venous disease: medical treatment alone or in addition to endovenous treatments. Advances in therapy, 2020, no 37(Suppl 1), pp. 13–18. https://doi.org/10.1007/s12325-019-01217-9

13. Derkachev S.N., Kobzar I.G., Selimov S.V., Figurkina M.A., Suchkov I.A. Evolution of surgical treatment methods for patients with varicose veins. I.P. Pavlov Russian Medical Biological Herald, 2025, no 33(4), pp. 599–610. (In Russ.) https://doi.org/10.17816/PAVLOVJ686883

14. Kamaev A.A., Bulatov V.L., Vakhratyan P.E., Volkov A.M., Volkov A.S., Gavrilov E.K., Golovina V.I., Efremova O.I., Ivanov O.O., Ilyukhin E.A., Katorkin S.E., Konchugova T.V., Kravcov P.F., Maksimov S.V., Mzhavanadze N.D., Pihanova Zh.M., Pryadko S.I., Smirnov A.A., Sushkov S.A., Chabbarov R.G., Shimanko A.I., Jakushkin S.N., Aphanova T.V., Derkachev S.N., Zolotuhin I.A., Kalinin R.E., Kirienko A.I., Kulchitskaya D.B., Pelevin A.V., Petrikov A.S., Rachin A.P., Seliverstov E.I., Stoyko Ju.M., Suchkov I.A. Varicose Veins. Journal of Venous Disorders, 2022, no 16(1), pp. 41–108. (In Russ.) https://doi.org/10.17116/flebo20221601141

15. Gloviczki P., Lawrence P.F., Wasan S.M., Meissner M.H., Almeida J., Brown K.R., Bush R.L., Di Iorio M., Fish J., Fukaya E., Gloviczki M L., Hingorani A., Jayaraj A., Kolluri R., Murad M.H., Obi A.T., Ozsvath K.J., Singh M.J., Vayuvegula S., Welch H.J. The 2023 Society for Vascular Surgery, American Venous Forum, and American Vein and Lymphatic Society clinical practice guidelines for the management of varicose veins of the lower extremities. Part II: Endorsed by the Society of Interventional Radiology and the Society for Vascular Medicine. Journal of vascular surgery. Venous and lymphatic disorders, 2023, no 12(1), pp. 101670. https://doi.org/10.1016/j.jvsv.2023.08.011

16. De Maeseneer M.G., Kakkos S.K., Aherne T., Baekgaard N., Black S., Blomgren L., Giannoukas A., Gohel M., de Graaf R., Hamel-Desnos C., Jawien A., Jaworucka-Kaczorowska A., Lattimer C.R., Mosti G., Noppeney T., van Rijn M.J., Stansby G., Esvs Guidelines Committee, Kolh P., Bastos Goncalves F., Vuylsteke M.E. Editor's Choice – European Society for Vascular Surgery (ESVS) 2022 clinical practice guidelines on the management of chronic venous disease of the lower limbs. European journal of vascular and endovascular surgery: the official journal of the European Society for Vascular Surgery, 2022, no 63(2), pp. 184–267. https://doi.org/10.1016/j.ejvs.2021.12.024

17. Pannier F., Noppeney T., Alm J., Breu F.X., Bruning G., Flessenkämper I., Gerlach H., Hartmann K., Kahle B., Kluess H., Mendoza E., Mühlberger D., Mumme A., Nüllen H., Rass K., Reich-Schupke S., Stenger D., Stücker M., Schmedt C.G., Schwarz T., Valesky E. S2k guidelines: diagnosis and treatment of varicose veins. S2k-Leitlinie diagnostik und therapie der varikose. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2022, no 73(Suppl 1), pp. 1–44. https://doi.org/10.1007/s00105-022-04977-8

18. Goshschynsky V.B., Migenko B.O., Migenko O.B. Comparative characteristics of endothelial dysfunction after endovascular laser vein ablation and classical saphenectomy for varicose veins of the lower extremities. Family medicine. European practices, 2024, no (3), pp. 6–11. (In Ukraine) https://doi.org/10.30841/2786-720X.3.2024.313965

19. Kalinin R.E., Suchkov I.A., Kamaev A.A., Mzhavanadze, N.D., Povarov V.O. Effects of low-energy EVLA with the use of a 1470-nm laser on vascular inflammation and remodeling parameters in patients with chronic venous disease. Lasers in medical science, 2025, no 40(1), pp. 516. https://doi.org/10.1007/s10103-025-04669-4

20. Suchkov I.A., Mzhavanadze N.D., Kalinin R.E., Shchulkin A.V., Kamaev A.A., Nikiforov A.A., Nikiforova L.V., Povarov V.O., Markitan G.S., Nazimova E.Yu. The effect of standardized doses of hesperidin and diosmin on venous wall remodeling in patients with primary varicose veins: a prospective controlled study “STANDARD”. Journal of Venous Disorders, 2024, no 18(4), pp. 293–301. (In Russ.) https://doi.org/10.17116/flebo202418041293

21. Kamaev A.A., Kalinin R.E., Mzhavanadze N.D., Povarov V.O., Yanykina K.V., Suchkov I.A. Effect of Sulodexide on Endothelial Function and Quality of Life in Patients with Varicose Veins. Journal of Venous Disorders, 2024, no 18(4), pp. 308–316. (In Russ.) https://doi.org/10.17116/flebo202418041308

22. Kamaev A.A., Kalinin R.E., Pshennikov A.S., Suchkov I.A. Pharmacological support strategies following endovenous laser ablation in patients with varicose veins. Pirogov Russian Journal of Surgery, 2025, no 12, pp. 119–130. (In Russ.) https://doi.org/10.17116/hirurgia2025121119

23. Zieliński A., Jasińska-Sumińska K., Bręborowicz A., Kowalska K., Zabel M., Wysocka T., Khalil R.A., Raffetto J.D., Urbanek T. Changes of the serum properties and its effect on the endothelial cells restoration in patients with chronic venous disease treated with sulodexide. J Vasc Surg Venous Lymphat Disord., 2024, no 12(5), pp. 101941. https://doi.org/10.1016/j.jvsv.2024.101941

24. Kakamad F.H., Tahir S.H., Mohammed Saeed D.H., Ahmed F.J., Hiwa D.S., Abdalla B.A., Mustafa A.M., Hassan M.N., Abdalla S.S., Sofi H.A., Karim S.O., Hamasaeed A.G., Kareem, P. M. Role of veno-active drugs after endovenous therapy: A systematic review of the current literature. Phlebology, 2025, no 40(10), pp. 729–740. https://doi.org/10.1177/02683555251337265

25. Karathanos C.S., Batzalexis K., Nana P., Spanos K., Kouvelos G., Rousas N., Giannoukas A. Prospective comparative study evaluating the role of flavonoids after endovenous thermal ablation. Phlebology, 2021, no 36(8), pp. 644–650. https://doi.org/10.1177/02683555211002331

26. Bogachev V.I., Boldin B.V., Turkin P.I. Perioperative administration of micronized purified flavonoid fraction in endovascular treatment of varicose disease. Angiology and vascular surgery, 2019, no 25(2), pp. 88–95. (In Russ.) https://doi.org/10.33529/angio2019214

27. Ilyukhin E.A., Kurginyan Kh.M., Kovalenko K.E., Norvardyan A.M., Abukhamdan A.S., Gevorgyan A.A., Kartoev I.R. Impact of micronized purified flavonoid fraction on venous symptoms after endovenous laser ablation: a randomized controlled trial DEMO. Journal of Venous Disorders, 2024, no 18(2), pp.122–131. (In Russ.) https://doi.org/10.17116/flebo202418021122

28. Bogachev V.I., Boldin B.V., Turkin P.I., Samenkov A.I. Efficacy of micronized purified flavonoid fraction in treatment of chronic venous oedema. Angiology and vascular surgery, 2020, no 26(2), pp. 86–94. (In Russ.) https://doi.org/10.33529/ANGI02020211

29. Rinaldi A., Zeno R., Peluso A., del Guercio L., Sodo M., Turchino D., Iandoli R., Costa D., Serra R., Bracale U. M. Efficacy of High-Dose Diosmin Therapy in Chronic Venous Disease Treated with Endovenous Ablation: A Quality-of-Life Analysis. Journal of Vascular Diseases, 2024, no 3(1), pp. 49–57. https://doi.org/10.3390/jvd3010004

30. Yang X., Jin J., Huang S., Qiu P., Wang R., Ye K., Lu, X. Clinical efficacy of sodium aescinate administration following endovenous laser ablation for varicose veins. Vascular, 2025, no 33(3), pp. 567–573. https://doi.org/10.1177/17085381241249288